Please Wait
Applying Filters...

Annual Sales of rotigotine transdermal patch reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 13,273Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Neupro

02 8Neupro Patch

PharmaCompass

01

Brand Name : Neupro

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 348

2018 Revenue in Millions : 350

Growth (%) : -1

blank

02

Brand Name : Neupro Patch

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro Patch

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 123

2019 Revenue in Millions : 127

Growth (%) : -3

blank

03

Brand Name : Neupro

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 376

2019 Revenue in Millions : 386

Growth (%) : -3

blank

04

Brand Name : Neupro Patch

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro Patch

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 97

2020 Revenue in Millions : 118

Growth (%) : -12

blank

05

Brand Name : Neupro

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 338

2020 Revenue in Millions : 376

Growth (%) : -1

blank

06

Brand Name : Neupro Patch

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro Patch

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 75

2021 Revenue in Millions : 97

Growth (%) : -23

blank

07

Brand Name : Neupro

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 325

2021 Revenue in Millions : 338

Growth (%) : -4

blank

08

Brand Name : Neupro Patch

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro Patch

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 57

2022 Revenue in Millions : 75

Growth (%) : -13

blank

09

Brand Name : Neupro

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 302

2022 Revenue in Millions : 325

Growth (%) : 9

blank

10

Brand Name : Neupro Patch

Rotigotine

arrow
34th IFSCC
Not Confirmed

Brand Name : Neupro Patch

arrow
34th IFSCC
Not Confirmed

Rotigotine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 99

2015 Revenue in Millions : 72

Growth (%) : 38

blank